Updated report on tools to measure outcomes of clinical trials in fragile X syndrome

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome

Abstract Objective Fragile X syndrome (FXS) has been the neurodevelopmental disorder with the most active translation of preclinical breakthroughs into clinical trials. This process has led to a critical assessment of outcome measures, which resulted in a comprehensive review published in 2013. Neve...

Full description

Bibliographic Details
Main Authors: Dejan B. Budimirovic, Elizabeth Berry-Kravis, Craig A. Erickson, Scott S. Hall, David Hessl, Allan L. Reiss, Margaret K. King, Leonard Abbeduto, Walter E. Kaufmann
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Journal of Neurodevelopmental Disorders
Subjects:
Fragile X syndrome
Clinical trials
Outcome measures
Intellectual disability
Autism spectrum disorder
Online Access:http://link.springer.com/article/10.1186/s11689-017-9193-x

Internet

http://link.springer.com/article/10.1186/s11689-017-9193-x

Similar Items